#United States #New York #Class Action #Pomerantz Law #POMDOCTOR

Pomerantz Law Firm Investor Alert on PomDoctor Ltd.

In a significant development for investors, Pomerantz LLP has announced the filing of a class action lawsuit against PomDoctor Ltd., which is traded on NASDAQ under the symbol POM. This lawsuit comes as a response to the controversies surrounding PomDoctor's rapid stock price surge and the subsequent fall that raised concerns of potential securities fraud.

Overview of the Situation

The class action pertains to allegations that PomDoctor, along with certain officers and directors, may have engaged in unlawful business practices, specifically securities fraud. During a brief yet intense period, the share price of PomDoctor escalated from an initial public offering (IPO) price of $4.00 to soaring heights of $6.09. This surge occurred without any substantial news that could vindicate such a remarkable price increase. In fact, recent investigations have brought to light that a fraudulent scheme may have been in play, utilizing social media to propagate misleading information about the company.

The Pump and Dump Scheme

Reports indicate that individuals were impersonating legitimate financial advisors to promote PomDoctor through various online platforms, including forums and social media. These imposter claims were sensational yet lacked any credibility, designed to generate a buying frenzy among retail investors. Unfortunately for many, these misleading tactics culminated in a catastrophic downfall of the stock price, which plummeted an astonishing 91% to just $0.50 on December 10, 2025.

Call to Action for Affected Investors

Pomerantz LLP has set a deadline of April 6, 2026, for investors who acquired PomDoctor securities during the defined Class Period to come forward and request to be appointed as Lead Plaintiff in this matter. Interested parties are encouraged to reach out to Danielle Peyton at the firm, either via email at [email protected] or by calling 646-581-9980, extension 7980. For those who reach out via email, it's advisable to include their mailing address, contact information, and details about the number of shares purchased.

Need for Legal Recourse

As one of the top firms specialized in corporate, securities, and antitrust class litigation, Pomerantz has a longstanding reputation for standing up against corporate misconduct. The firm was founded by the late Abraham L. Pomerantz, who is recognized as a pioneer in advancing securities class actions. In its more than 85 years of existence, Pomerantz has successfully claimed numerous multimillion-dollar awards for class members who have found themselves victims of fraud or breaches of fiduciary duty.

How to Stay Informed and Involved

For those interested in learning more about the complaint and the class action, further information can be found at pomerantzlaw.com. This website provides updates on the lawsuit and insight into the procedures for joining the action.

Conclusion

Investors who feel they may have been misled by PomDoctor's actions have a crucial opportunity to seek justice through this class action lawsuit. The Pomerantz Law Firm is actively seeking to protect the rights of those affected, underscoring their commitment to justice within the realm of securities trading. As the situation continues to develop, keeping abreast of updates from Pomerantz will be essential for all potential and current investors in PomDoctor Ltd.